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Background/Introduction
Though the regression of Pulmonary Arterial Hypertension (PAH) in mitral stenosis (MS) has been studied over varying periods post-intervention, corresponding studies on the cardiac chamber alterations after surgery are very limited.
Aims/Objectives
We sought to determine the degree of reversal of these and the clinical status in connection with that of Pulmonary artery pressures (PAP).
Method
The pre and one-year postoperative data;-{Functional Class (FC), cardiothoracic ratio (CTR) in chest x-ray, and echocardiographically Left atrium (LA), Right atrium (RA), Right ventricle (RV), left ventricle (LV), & Pulmonary Artery (PA) dimensions, PAP, tricuspid regurgitation (TR)}, of 50 patients who had Mitral valve replacement (MVR) for MS with PAH, were retrospectively analysed for correlations with PAP (Pearson's), and the change in each (t-test), in relation to that in PAP. PAH groupbased (Group-I PAP ≥60 mmHg, Group-II >60 mmHg) analysis was done and the differences highlighted. 
Discussion/Conclusion
Conclusions: This study emphasizes the importance of the baseline PAP in MS, to which was proportionate the functional disability & the cardiac chamber alterations (except LA). An improvement in these accompanied the postoperative PAP regression, though not all were directly proportionate with PAP. The higher-pressure group showed greater degree of regression, but also greater prevalence of residual abnormalities (most except LA), suggesting that the pathologic changes in them might take longer to resolve, which needs further evaluation.
